CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
TEE probedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06154265
NCT06154265N/ACompleted

Default vs As-Needed Intraoperative Transesophageal Echocardiography (TEE) in Low-Risk Isolated Coronary Artery Bypass Graft (CABG) Surgery: A Randomized Controlled Trial

University of Pennsylvania·interventional·Posted Dec 4, 2023·Updated May 12, 2026

In Brief

A clinical study evaluating TEE probe for Heart Diseases and 4 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This goal of this study is to better understand when and where intraoperative transesophageal echocardiography (TEE) should (or should not) be used during coronary artery bypass graft (CABG) surgeries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedDec 4, 2023
Enrollment StartJan 22, 2024
Primary CompletionMar 15, 2025
Study CompletionMar 15, 2026
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.6 years ago

Interventions

TEE probedevice

Transesophageal echocardiography, ultrasound probe